This Event has Passed
Monday, April 15, 2019 - 8:00 AM
to Wednesday, April 17, 2019 - 5:00 PM
8:00 AM - 5:00 PM See all dates and Times
http://go.evvnt.com/286272-2?pid=2809
The World Drug Safety Congress Americas for over 10 years has served as the only commercially focused event for the pharmacovigilance community. In 2018, we were proud to be the only event to gather over 30 Global Heads of PV from the leading
pharmaceutical companies including Merck, Novartis, Roche, Pfizer, Astellas, Boehringer Ingelheim, CSL Behring, Alnylam, Shire, Kite-Gilead, AstraZeneca, Moderna, Zogenix, Intarcia, GlaxoSmithKline, Quark, Portola, Celgene, Keyrus, Taimei, Fibrogen and Genzyme.
Due to overwhelming demand from the community we will be adding a predictive safety and medical device focus to the event. We will also include perspectives on global pharmacovigilance from stakeholders outside the U.S.
pharmaceutical companies including Merck, Novartis, Roche, Pfizer, Astellas, Boehringer Ingelheim, CSL Behring, Alnylam, Shire, Kite-Gilead, AstraZeneca, Moderna, Zogenix, Intarcia, GlaxoSmithKline, Quark, Portola, Celgene, Keyrus, Taimei, Fibrogen and Genzyme.
Due to overwhelming demand from the community we will be adding a predictive safety and medical device focus to the event. We will also include perspectives on global pharmacovigilance from stakeholders outside the U.S.
